SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is generating intense community buzz as the company ramps up R2 production and provides investors with delivery window estimates, fueling debates over potential volume growth and long-term production scaling. While some investors remain cautious about management's communication and volatility, others are aggressively accumulating shares, pointing to strong R2 demand and strategic partnerships as catalysts for a potential fundamental revaluation.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is facing significant selling pressure amid market concerns that Meta's reported plans to monetize excess AI computing capacity could increase competition and diminish demand for specialized neocloud providers. However, the community remains deeply divided, with many long-term bulls dismissing the news as market manipulation or a misunderstanding of existing multi-year supply contracts, choosing to view the steep pullback as a buying opportunity.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing high volatility as investors rotate out of semiconductor stocks following a report that Meta may monetize excess AI infrastructure, sparking fears of overcapacity. While retail investors remain divided between panic selling and capitalizing on the dip, many are actively monitoring technical support levels and potential long-term buy-in opportunities amid the broader sector correction.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors anticipate upcoming global expansion news and potential catalysts in July, with community members actively discussing the company's NK cell platform and its potential to disrupt traditional cancer treatments. Bullish sentiment is heavily fueled by high short interest and anticipation of a potential squeeze, as supporters rally around the company's progress in clinical trials and manufacturing infrastructure.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending due to heightened community interest in its potential for a short squeeze, driven by significant short interest and optimism surrounding its international expansion and Alani Nu growth. Investors are actively debating the company's long-term valuation compared to sector competitors, with many looking toward an upcoming earnings catalyst to break the stock out of its recent consolidation.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc. is trending as investors aggressively rotate into Physical AI infrastructure, fueled by the company's recent Build America, Buy America (BABA) compliance for its Rev8 LiDAR and a high-volume manufacturing partnership with Benchmark Electronics. The community is heavily focused on the company's role as a critical sensing layer for robotics, autonomous machinery, and smart city infrastructure, with widespread discussion around the potential for a major valuation rerating as these technologies move toward large-scale deployment.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors react to a positive analyst upgrade from Guggenheim, which reframed the stock's AI workflow integration as a significant long-term growth catalyst rather than a risk. The community is actively debating the sector's performance, expressing frustration over the stock's inverse correlation with semiconductor plays while remaining bullish on its long-term potential as an enterprise AI powerhouse.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending downward following reports that Meta plans to launch a cloud business to monetize its own excess AI compute capacity, sparking investor fears over potential hyperscaler competition. While some market participants see this as a temporary narrative shift and an overreaction given CoreWeave's long-term contracted backlog, others in the community are concerned about the impact of hyperscaler entry on the broader neocloud business model.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as investors digest insider share purchases and ongoing development of its L4 autonomous trucking platform. The community remains heavily focused on the stock's long-term commercialization milestones and the potential for a short squeeze as the company navigates high volatility and significant short interest.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending as investors debate its long-term growth potential and platform expansion compared to larger brokerage peers, while a vocal community segment focuses on technical support levels and recent institutional accumulation. Sentiment remains deeply divided, with some traders optimistic about a potential breakout driven by platform scaling, while others express frustration over persistent price stagnation and perceived market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO for NSCLC

Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO for NSCLC Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical...

Why Astrazeneca (AZN) Dipped More Than Broader Market Today

Astrazeneca (AZN) closed at $183.86 in the latest trading session, marking a -3.04% move from the prior day.

AZN vs. ILMN: Which Stock Should Value Investors Buy Now?

AZN vs. ILMN: Which Stock Is the Better Value Option?

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

J&J's Innovative Medicine Business in Q2: Here's What to Watch

JNJ's Q2 Innovative Medicine results face scrutiny as Stelara biosimilar pressure offsets growth from key blockbusters and newer therapies ahead of earnings.

AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors (Revised)

AZN's Enhertu wins its sixth EU indication with a tumor-agnostic approval. Datroway moves closer to a first-line TNBC EU nod following a positive CHMP opinion.

AstraZeneca Advances Rare Bone Disease Pipeline While Enhertu Expands In Europe

AstraZeneca reported positive HPP trial data while Enhertu gained EU approval for HER2-positive solid tumors.read more...

AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors

Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note

In the most recent trading session, Astrazeneca (AZN) closed at $185.68, indicating a +1.45% shift from the previous trading day.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$183.86
Prev Close	$189.62
Open	$187.07
Dividend Yield	1.68%
50-Day Moving Average	$184.21
Beta	0.40
Avg. Volume	2.07M
PE Ratio	27.43

52-Week High	$212.71
52-Week Low	$137.23
Market Capitalization	$285.14B
EPS (Annual)	$6.60
Price to Book	6.02
Revenue Per Employee	$611,227.89

Feed

News

Sentiment

Earnings

Fundamentals

Info

AZNAstraZeneca PLC

Latest AZN News